Stahl et al. J Clin Oncol 2009
CT
CRT
3-year survival: 27.7% (arm A) vs. 47.4% (arm B); p=0.07
Esophageal cancer:
Neo-adjuvant Chemoradiotherapy or Chemotherapy?
EBRO
2017EBRO
2017